Kimelman & Baird LLC Sells 61,878 Shares of Teleflex Incorporated $TFX

Key Points

• Kimelman & Baird LLC reduced its stake in Teleflex Incorporated by 94.8%, holding only 3,382 shares after selling 61,878 shares in the first quarter, valued at $467,000.
• Teleflex's latest earnings report showed $3.73 EPS, exceeding analyst expectations, with quarterly revenue of $780.90 million, reflecting a 4.2% year-over-year increase.
• The company has recently announced a quarterly dividend of $0.34, with a yield of 1.1%, to be paid on September 15th, following an ex-dividend date of August 15th.

Kimelman & Baird LLC reduced its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 94.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 3,382 shares of the medical technology company's stock after selling 61,878 shares during the period. Kimelman & Baird LLC's holdings in Teleflex were worth $467,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Sterling Capital Management LLC lifted its holdings in Teleflex by 55.5% in the 4th quarter. Sterling Capital Management LLC now owns 2,791 shares of the medical technology company's stock worth $497,000 after buying an additional 996 shares in the last quarter. Barclays PLC raised its holdings in shares of Teleflex by 20.9% during the fourth quarter. Barclays PLC now owns 108,689 shares of the medical technology company's stock valued at $19,344,000 after buying an additional 18,782 shares during the last quarter. Mariner LLC grew its position in Teleflex by 7.9% in the 4th quarter. Mariner LLC now owns 5,430 shares of the medical technology company's stock valued at $966,000 after buying an additional 396 shares in the last quarter. Walleye Capital LLC lifted its holdings in shares of Teleflex by 420.2% in the fourth quarter. Walleye Capital LLC now owns 6,695 shares of the medical technology company's stock valued at $1,192,000 after buying an additional 5,408 shares during the period. Finally, Canada Post Corp Registered Pension Plan bought a new position in shares of Teleflex in the fourth quarter valued at $68,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Royal Bank Of Canada lifted their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research note on Friday, August 1st. Morgan Stanley decreased their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. Mizuho lifted their price objective on Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a report on Friday, August 1st. Wall Street Zen upgraded Teleflex from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Finally, Wells Fargo & Company decreased their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Teleflex presently has a consensus rating of "Hold" and an average price target of $141.57.

Teleflex Stock Up 3.5%

Shares of TFX traded up $4.2240 on Tuesday, hitting $124.0840. The company's stock had a trading volume of 560,568 shares, compared to its average volume of 793,295. The firm has a market capitalization of $5.48 billion, a price-to-earnings ratio of 29.20, a P/E/G ratio of 1.68 and a beta of 1.08. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The firm's fifty day moving average price is $117.87 and its 200-day moving average price is $131.70. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. During the same quarter in the previous year, the firm posted $3.42 EPS. Teleflex's revenue was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, equities research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Friday, August 15th. Teleflex's dividend payout ratio is 32.00%.

Insider Activity

In related news, Director Jaewon Ryu purchased 1,500 shares of Teleflex stock in a transaction dated Tuesday, August 5th. The stock was bought at an average cost of $115.00 per share, for a total transaction of $172,500.00. Following the completion of the transaction, the director owned 3,727 shares in the company, valued at $428,605. This trade represents a 67.36% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gretchen R. Haggerty acquired 500 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The stock was bought at an average price of $114.75 per share, for a total transaction of $57,375.00. Following the completion of the transaction, the director owned 6,305 shares of the company's stock, valued at $723,498.75. The trade was a 8.61% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 5,500 shares of company stock worth $633,590. 1.40% of the stock is owned by company insiders.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.